Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation <i>in vitro</i>
John Fisher, Michael J. Rogers, J. M. Halasy, Steven P. Luckman, D.E. Hughes, P. Masarachia, Gregg Wesolowski, R.G.G. Russell, Gideon A. Rodan, A A Reszka
Proceedings of the National Academy of Sciences, 1999
Abstract
This research paper explore the methodology and findings associated with Proceedings of the National Academy of Sciences. The study delves into the core aspects of the research field, providing significant data and citation impact. (Full abstract processing is available via the OpenAlex API).